{
  "docId": "019dd923-622c-750b-8b9b-9646c0061f4f",
  "docSlug": "002774f67694",
  "documentTitle": "Valeant Pharmaceuticals International (VRX)",
  "authorId": "01_Pershing_Square",
  "authorName": "William Ackman",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2015-05-04 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 47,
  "pageCount": 47,
  "prevPage": 46,
  "nextPage": null,
  "slideType": "appendix_data",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 5,
  "notes": "The slide details the logic for M&A spending caps and the subsequent use of excess debt capacity for share repurchases.",
  "elementsJson": [
    "headline_text",
    "bullet_list"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9b-9646c0061f4f/47",
  "deckHref": "/decks/019dd923-622c-750b-8b9b-9646c0061f4f",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9b-9646c0061f4f.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-9646c0061f4f#slide-47",
  "components": [
    {
      "bbox": {
        "h": 0.215,
        "w": 0.885,
        "x": 0.115,
        "y": 0.305
      },
      "kind": "list",
      "text": "Acquisition financing and timing: Acquisitions are cash financed; Acquisitions are made at start of year; Valeant acquires assets until annual M&A cap or leverage limit (4x Net Debt/Pro-Forma LTM EBITDA) is reached",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "39e92a73-b0dc-4f77-8d6a-84a599026ddd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.075,
        "w": 0.885,
        "x": 0.115,
        "y": 0.805
      },
      "kind": "list",
      "text": "If Valeant has additional debt capacity (up to 4x) after acquisitions, cash is used to buy back stock at 18x trailing earnings",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6e0ff7eb-bc61-4b37-931a-5ea35b5e8ce3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.215,
        "w": 0.55,
        "x": 0.115,
        "y": 0.545
      },
      "kind": "list",
      "text": "Four acquisition cases: $0bn of acquisitions per year; Up to $5bn of acquisitions per year; Up to $10bn of acquisitions per year; Up to $20bn of acquisitions per year",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7b2c1e33-8af4-4b32-bc12-a02cd949edf8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.055,
        "w": 0.909,
        "x": 0.088,
        "y": 0.215
      },
      "kind": "paragraph",
      "text": "Uses of cash",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "666a6ca4-bdff-4d2a-b937-88d9547516ea",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.088,
        "w": 0.745,
        "x": 0.088,
        "y": 0.102
      },
      "kind": "title",
      "text": "Platform Valuation Model Assumptions - Sources and Uses of Cash",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3acd53c9-2e1e-4bbe-8931-f3e172bc845b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "ae0f845b-0bed-4921-9003-8c2f7d27476d",
      "evidence": "list/bullet: Acquisition financing and timing: Acquisitions are cash financed; Acquisitions are made at start of year; Valeant acquires assets until annual M&A cap or leverage limit (4x Net Debt/Pro-Forma LTM EBITDA) is",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}